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Background: Aging of the immune system, known as immunosenescence, is associated with profound changes in
both innate and adaptive immune responses, resulting in increased susceptibility to infection and a decreased
ability to respond to vaccination. The purpose of this study was to investigate the effect of age and menopause on
the expression of 22 different cytokines/chemokines in both plasma and cervical lavage samples from female sex-
worker cohort from Nairobi, Kenya (age range 20–65).
Results: Cytokine/chemokine levels were measured using a Miliplex multiplex assay (Millipore). We found that age
positively correlated with MCP-1 (p = 0.0002) and IP-10 (p = 0.03) systemic cytokine expression, and that women
over 50 expressed the highest levels of these cytokines, but also had elevated expression of MIG (ANOVA p =
0.0096) and MIP-3β(ANOVA p = 0.0434). We also found that IL-8 (p = 0.047) and sCD40L (p = 0.01) systemic
expression negatively correlated with age. Further, MIG (p = 0.0081) and MCP-1 (p = 0.0157) were present at higher
levels in post-menopausal women suggesting a potential estrogen dependant systemic regulation of these
cytokines. In cervical lavage samples, age did not directly correlate with the expression of any of the tested
cytokines/chemokines, however sIL-2Rα (ANOVA p = 0.0170) and IL-15 (ANOVA p = 0.0251)were significantly higher
in women over 50. Menopause was shown to have a more profound effect on cytokine expression in the cervical
mucosa with MIG (p = 0.0256), MIP-3α (p = 0.0245), IL-1β (p = 0.0261), IL-6 (p = 0.0462), IL-8 (p = 0.007), IP-10 (p =
0.0357) and MCP-1 (p = 0.0427) all significantly under-expressed in post-menopausal women.
Conclusions: This study demonstrates that aging and menopause-associated hormonal changes are associated
with significant changes in systemic and mucosal cytokine/chemokine expression, which may have implications for
the age-related decline in the ability to fight against infections.
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One of the great successes of modern society is the glo-
bal increase in life expectancy; in part due to greater
control of infectious diseases, better living conditions,
better nutrition and new medical technologies [1-3].
Furthermore, the gap between the life expectancy of
populations in developed and developing countries is de-
creasing. This increase in aging population is seen as a
success story for socioeconomic development and public
health policies; however it also poses new challenges on
the health care system. In order to provide appropriate
health care to the elderly, a better understanding of how
age impacts the immune system and susceptibility to
disease is needed.
Globally, increase in the number of elderly individuals
has resulted in increased incidence of cancer and auto-
immune disorders [3-7]. Importantly, aging is also asso-
ciated with defects in the immune response to multiple
infections [5,8,9]. In fact, aging has been associated with
decrease in lymphocyte proliferative responses, reduced
delayed type hypersensitivity reactions and decreased
antibody responses to vaccination and infection [9-11].
Generally, increased age is characterized by a decreased
ability to generate effective immune response to foreign
antigens, which impairs the ability to fight against infec-
tions. It is generally believed that this occurs due to a
decrease in function and number of naïve T cells
[11-15]. The ratio of naïve to memory T cells has been
shown to decrease with age, due to the fact that most
naïve T cells have been previously exposed to antigens
and fewer T cells are produced in the thymus
[3,11,13-16]. Defects in T cell signaling in both CD4+
and CD8+ subsets have been described [11,17-19]. Add-
itionally aging has been associated with higher number
of T regulatory (Treg) cells [5,18-21], a decline in B cell
production and humoral immunity [21-24], chronic im-
mune activation [23,25,26] and a shift from Th1 [Inter-
leukin (IL-)2, Interferon-gamma (IFN-γ)] to a Th2-like
cytokine response (IL-4, IL-6, IL10) [26,27]. All these
data suggest that the ability of an older individual to re-
spond appropriately to an immunological challenge is
compromised thorough variety of mechanisms.
Age associated alterations in immune environment
have predominantly been studied in systemic compart-
ments and far less is known about the impact aging has
on the mucosal immune responses. The elderly have
been characterized with higher rates of morbidity and
mortality due to infectious diseases of the intestinal tract
and a general mucosal immunosenescence [18]. This is
evidenced by findings showing that the development
of mucosal immune response to new antigens at the
gastrointestinal tract (GI) diminishes with age [19].
However, studies looking at aging in women and the
associated changes in immune environment of themucosal compartment, especially the cervical mucosa,
are currently lacking.
In addition to aging, the onset of menopause, and the
associated decline in estrogen levels play a critical
role in regulating the immune response in women.
Hormones are immune regulators that can modify
both the systemic and mucosal immune system [28,29].
Important changes in cell populations and cytokine/che-
mokine production are observed during the menstrual
cycle at the female genital tract (FGT) [29]. After
menopause there is an increase in pro-inflammatory
serum markers such as IL-1, IL-6 and TNF-α, a decrease
in CD4 T and B lymphocytes and a decrease in the cyto-
toxic potential of natural killer (NK) cells [11].
Since cytokines and chemokines play an important
role in modulating the immune system it is important to
understand how their expression might change with age.
In this study, we look at the impact of age and meno-
pause on the systemic and cervical mucosal expression
of 22 cytokines/chemokines. To our knowledge this is
the first study to look at the impact of both age and
menopause on cytokines and chemokines important in
immune cell trafficking and inflammation in both sys-
temic and mucosal compartments.
Results
Study participants characteristics
Only HIV-ve individuals were used in this study. Add-
itionally, because other sexually transmitted diseases can
greatly influence the expression of cytokines/chemokines
at the systemic and mucosal level, all participants who
tested positive for the presence of bacterial vaginosis,
Nisseria gonorrhoeae, and/or Chlamydia were excluded
from the analysis (n = 26). Overall 176 subjects were en-
rolled, resulting in 176 plasma samples and 154 CVL
samples (where available) that were included in the final
analysis. Due to sample volume limitations, this was the
case for all tested cytokines/chemokines except MIP-3β
and IL-12p70 (assayed for n = 79 for both plasma and
CVL). Age range for patients where plasma samples
were analyzed was 20 to 65 (median age: 38) and age
range for patients providing CVL samples was 21–65
(median age: 39). Other socio-demographic characteris-
tics were similar between the compared groups (not
shown).
Plasma cytokine/chemokine levels
To determine what cytokines and chemokines were al-
tered due to age we correlated the expression of each
specific cytokine/chemokine examined with the subject’s
age using Spearman correlation analysis (Additional file
1: Table S1). We observed that the expression of MCP-1
(p = 0.0002) and IP-10 (p = 0.03) positively correlated
with age. In contrast we found that the systemic
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negatively correlated with the age of the women studied
(Figure 1). To better understand the distribution of
differences in cytokine expression based on age, we
subdivided the data into the following age groups: young
(<30 years), middle-aged (30–50 years) and old (>50
years) as done elsewhere [30]. We found that MCP-1
and IP-10 levels were highest in women above 50 years
of age compared to the other two age groups (ANOVA
p = 0.026 and p = 0.004 respectively, Figure 2). Interest-
ingly we found that MIP-3β (ANOVA p = 0.0434) and
MIG (ANOVA p = 0.0096) were also highly expressed in
women over 50 (Figure 2). No significant differences
were observed between <30 and 30–50 age groups for
any of the above-mentioned cytokines, suggesting that
the age effect on the expression of the pro-inflammatory
cytokines/chemokines MCP-1, IP-10, MIG and MIP-3β
is more pronounced in older women (> 50 years of age).
Overall, these data show that MCP-1, IP-10, MIG,
MIP-3β, sCD40L and IL-8 may be important indicators of
age-related changes in the systemic immune environment.
Studies suggest that in addition to age, changes in the
immune environment can be attributed to the hormonal
changes associated with menopause transition [11]. To
determine the effect of menopause on the systemic ex-
pression of studied cytokines/chemokines we segregated
the samples into pre-menopausal (n = 140) and post-
menopausal (n = 29). Some of the studied women were
menopausal before age of 50 (n = 9), and some women
above 50 years of age were not menopausal (n = 4).Figure 1 Spearman correlation of age (years) and plasma cytokines/c
correlations were shown for the rest of the data refer to Additional file 1: T
purposes only.When we examined the expression differences between
these two groups we found that plasma levels of MIG
(p = 0.0081) and MCP-1 (p = 0.0157) were significantly
higher in post-menopausal women (Figure 3) suggesting
a potential hormonal regulation of these cytokines. As
these cytokines were also significantly affected by age,
we ran linear regression models with MCP-1 and MIG
as a dependent variable and age and menopause as co-
variates (Additional file 1: Table S3). Linear regression
model indicates that MCP-1 is primarily affected by age
(p = 0.004) but not menopause (p = 0.449), while MIG
expression was significantly affected by menopause
(0.049) but not age (p = 0.280).
CVL cytokine/chemokine levels
Despite recent advances in understanding the aging im-
mune system, studies looking at the effect of aging on
the immune environment of the mucosal compartment,
especially the cervical mucosa, are lacking. To investi-
gate the impact of aging on mucosal cytokine/chemo-
kine expression, Spearman correlation analysis was used
to correlate cervical lavage cytokine/chemokine expres-
sion with age. We observed no significant correlations
between the mucosal expression of the studied cyto-
kines/chemokines and women’s age (Additional file 1:
Table S2). Again, we subdivided the women to examine
if there were any differences in cytokine/chemokine
expression between specific age groups (<30; 30–50; >50).
We found that the expression of sIL-2Ra (ANOVA p =
0.0170) and IL-15 (ANOVA p = 0.0251) were significantlyhemokines concentration (pg/ml). Only statistically significant
ables S1 and S2. Linear regression line was added for visualization
Figure 2 Plasma cytokine/chemokine expression (pg/ml) grouped by age: younger (<30), middle-aged (30–50) and older (>50) women.
Overall significance was determined using a Kruskal-Wallis test, and intergroup differences were examined using Mann–Whitney test (p < 0.05).
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ger (<30) women (Figure 4). It would seem that the effect
of age on the cervical immune environment in younger
women is not as apparent and larger differences are ob-
served in higher age groups, possibly due to physiological
and behavioral factors.
Because estrogen deprivation is an important factor
that can influence the cytokine/chemokine expression in
the FGT, we next compared the cytokine/chemokineFigure 3 Plasma cytokine/chemokine expression (pg/ml) in post-menopa
test was used to examine significance (p < 0.05).expression between pre-menopausal (n = 135) and post-
menopausal (n = 29) women. Some of the studied
women were menopausal before age of 50 (n = 5), and
some women above 50 years of age were not meno-
pausal (n = 4). We observed that the level of MIG (p =
0.0256), MIP-3α (p = 0.0245), IL-1β (p = 0.0261), IL-6
(p = 0.0462), IL-8 (p = 0.007), IP-10 (p = 0.0357) and
MCP-1 (p = 0.0427) were all significantly elevated in
women pre-menopause compared with women post-usal (n = 29) and pre-menopausal (n = 140) women. Mann–Whitney
Figure 4 CVL cytokine/chemokine expression (pg/ml) grouped by age: younger (<30), middle-aged (30–50) and older (>50) women.
Overall significance was determined using a Kruskal-Wallis test, and intergroup differences were examined using Mann–Whitney test (p < 0.05).
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pro-inflammatory markers in cervical lavage samples of
post-menopausal women and this could potentially
contribute to higher susceptibility to microbial invasion
and infection of the FGT observed post-menopause.
Discussion
Aging is associated with deregulation and general de-
cline in immune responses contributing to increased
susceptibility to infection. Human–based data looking at
the association between aging and immune response is
particularly sparse, with majority of the studies pub-
lished so far based on rodent models. Furthermore,
limited data is available on the impact of aging and
menopause on human cytokine/chemokine expression in
different tissues. Herein, we showed an association be-
tween both age and menopause and cytokine/chemokine
expression in plasma and cervical lavage samples from
female sex workers in Nairobi, Kenya.
Age related changes in plasma and CVL cytokine/
chemokine expression
We observed a number of age related changes in plasma
cytokine/chemokine expression. Systemic expression of
MCP-1 and IP-10 positively correlated with women’s
age. Consistent with our data, Seidler et al. showed that
in healthy adults, serum concentration of MCP-1, but
not MIP-1α, MIP-1β and fractalkine increased with age
[30]. MCP-1, a chemoattractant for monocytes and
lymphocytes mainly produced by endothelial cells and
macrophages, is involved in the inflammation process
[31] and is reported to be involved in Th2 polarization
[32]. Increasing concentrations of MCP-1 in older indi-
viduals could partly be responsible for development of
arthrosclerosis and an age dependant shift in Th1/Th2
responses [33]. IP-10 is an interferon-gamma inducible
protein predominantly produced by monocytes and plays
an important role in leukocyte trafficking by promotingthe migration of NK cells and activated and memory T
cells but not naïve T cells [33,34]. Interestingly, in elderly
individuals the number of naïve T cells is low and it is
conceivable that a higher concentration of IP-10 is
required due to the higher number of memory T cells
observed with age. Additionally IP-10 is a strong chemo-
attractant for Th1 lymphocytes and is considered to be a
reliable marker of strong Th1- mediated autoimmune
disease [35]. Our data agrees with the previous observa-
tions that an age-dependant increases in both MCP-1
and IP-10 chemokines in healthy women may affect both
Th1 and Th2 phenotypes and contribute to the overall
impairment of the immune system.
When we separated women into age groups (<30,
30–50 and >50) the expression of MCP-1 and IP-10
remained significant. Both MCP-1 and IP-10 were ele-
vated in older women (>50 years old), suggesting that
the expression of these 2 chemokines is predominantly
associated with the higher end of the age distribution.
Additionally, when we looked at the cytokine/chemokine
expression in different age groups, MIG and MIP-3β
were significantly higher in women aged >50. Interest-
ingly, MIG and IP-10 belong to the same family of
chemokines, suggesting that the IFN-gamma inducible
pathway is influenced by age. To our knowledge this is
the first study to show association of systemic MIP-3β
and age. MIP-3β is produced by DCs and possibly other
lymphocytes and has the ability to chemoattract T cells,
B cells, macrophages and NK cells. MIP-3β could be one
of the contributing factors in age dependant deregula-
tion of the innate and adaptive immune responses.
Additionally we observed a negative association be-
tween age and IL-8 and sCD40L systemic expression.
IL-8 is produced by macrophages and plays an import-
ant role in neutrophil recruitment. The percentage of T
cells producing IL-8 has been shown to decrease with
age in the acutely ill Malawian patients [36] and spon-
taneous production of IL-8 was found to be significantly
Figure 5 CVL cytokine/chemokine expression (pg/ml) in post-menopausal (n = 29) and pre-menopausal (n = 135) women. Mann–Whitney test
was used to examine significance (p < 0.05).
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with the previous observations, suggesting that age is an
important factor in IL-8 production. This age-dependant
decrease in IL-8 production could contribute to the
altered neutrophil function including reduced chemo-
taxis observed in older individuals [38]. Major sources of
soluble CD40L are activated T lymphocytes andplatelets. CD40L plays an important role in activation of
antigen presenting cells (APCs) and regulation of B cell
proliferation, adhesion and differentiation by interacting
with its receptor, CD40. Significantly reduced CD40L ex-
pression by the aged CD4 T cells was observed in mice
[39]. Lower CD40L expression was observed on lympho-
cytes from older subjects as well [40,41]. Aging has been
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[42] and this might contribute to decreased sCD40L
production observed here. Consequently, this decrease
in sCD40L could contribute to age related B cell deregu-
lation [22].
To the best of our knowledge we are the first to exam-
ine the effect of age on the immune environment in cer-
vical lavage samples. Interestingly, in this study no direct
correlation was observed between the mucosal cytokine/
chemokine expression and age overall. However, when
we divided the women in three different age groups, we
observed that the expression of sIL-2Rα and IL-15 was
significantly higher in women above 50 years of age
compared to younger women (<30). An increase in IL-
15 mRNA was shown to be associated with aging in
mouse model [9] and higher IL-15 serum levels were
reported in ultralongeval individuals (>95) [43]. A rela-
tive increase in sIL-2Ra release by aged cells despite
lower surface expression was reported previously [1]. IL-
15 is known to play a role in T cell homeostasis and
could contribute to the age associated decrease in naïve
to memory T cell ratio [3-5] as well as increase in Treg
cell numbers [5]. Additionally, increased IL-15 mRNA
expression was observed in aging muscles in mice stud-
ies. This is thought to be an age-related adaptation of
skeletal muscle to counter muscle atrophy through IL-
15 mediated increase in myosin heavy chain protein con-
tent [9]. Aging and the associated muscle loss of the
FGT could potentially contribute to increase in IL-15
observed here.
Menopause related changes in plasma and CVL cytokine/
chemokine expression
Menopause is associated with important physiological
and immunological changes. The decline in production
of estrogen associated with ageing in women has been
linked with important changes in cell population and
cytokine expression [11]. Keeping this idea in mind, we
looked at the cytokine/chemokine expression in women
depending on their menopause status.
In the systemic compartment, expression of MIG and
MCP-1 were higher in post-menopausal women. MIG
did not directly correlate with age however it was signifi-
cantly higher in women above 50 years of age. Multivari-
ate analysis indicates that MCP-1 is primarily affected by
age, while MIG expression was primarily affected by the
menopause status. It has been previously shown that
MCP-1 expression is inhibited by estrogen therapy lead-
ing to decrease in macrophage recruitment [13-15]. Fur-
ther studies are needed to determine weather increase in
MIG and MCP-1 expression could in part be explained
by menopause-associated decrease in estrogen levels.
Interestingly, when we looked at the impact of meno-
pause status on the cytokine/chemokine expression inCVL we observed a higher impact when compared to
plasma. Indeed, at the mucosal environment, it seems
that the menopause associated estrogen deprivation has
a bigger impact than age itself. Menopause status was
significantly associated with lower mucosal expression of
MIG, MIP-3α, IL-1b, IL-6, IL-8, IP-10 and MCP-1.
Previous data showed an association of menopause with
a decrease in T cell and B cell populations [11]. This
decrease in the lymphocyte population may be cause,
or effect of the altered mucosal cytokine/chemokine
expression observed in our study. Our data seems to
indicate that post-menopausal women might have a
lower capacity to generate a strong, inflammatory muco-
sal immune response, which matches the findings from
the GI mucosa [18,19]. Vaginal infections, especially
yeast infections, are one of the main symptoms of
menopause. Menopause is associated with physiological
changes in the urogenital epithelium including thinning
out, loss of elasticity and increase in vaginal pH [21].
These menopause-associated physiological changes in
the FGT tissue result in increased ability of pathogens to
establish infection. In addition to this, decreased pro-
inflammatory cytokine/chemokine expression observed
in our study could potentially contribute to increased
susceptibility to microbial invasion and infection ob-
served post-menopause. To our knowledge this is the
first study to examine the effect of age and menopause
status on cytokine/chemokine expression in CVL.
Some study limitations must be addressed. In this
study we are looking at a specific population composed
only of women age range 20–65 involved in sex worker
cohort in Nairobi, Kenya, which might account for some
of the difference between our study and others. Even if
sex work has less or no impact on the systemic cyto-
kine/chemokine expression, it is known to have an
impact on the mucosal cytokine/chemokine expression
dynamics (Lajoie et al., submitted). It is also important
to note that p-values were discussed as observed without
correction for multiple comparisons to avoid false nega-
tive results. Further investigations looking at changes in
cell populations both systemically and mucosaly, are
needed in order to fully understand the impact of age
and menopause- associated hormonal changes on the
immune environment.
Summary
Our study demonstrates dynamic changes in systemic
and cervical mucosa cytokine/chemokine expression
during ageing in women. To the best of our knowledge
this is the first extensive study that analyzed the impact
of age and menopause status on cytokine/chemokine
production in both the systemic and cervical mucosal
compartment of African women. We have shown that sig-
nificant differences exist in the way age and menopause-
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cosal cytokine/chemokine expression. Additionally, we have
demonstrated that age and menopause impact on cytokine/
chemokine expression differs between tissues highlighting
the need for more specific tissue-based studies. Further
understanding of how these changes affect susceptibility to
infection and response to vaccination is crucial to the devel-
opment of new therapies targeted at enhancing immune
response in the elderly.
Methods
Study population
Samples used for this study were obtained from the
Pumwani Sex Worker Cohort in Nairobi, Kenya established
in 1985 [23]. Overall, 176 HIV-negative individuals were in-
volved in this study. Participants of the cohort are assessed
twice a year for follow-up. Prior to sample collection each
woman enrolled in the study answered a questionnaire and
the following information was collected: sociodemographic,
sexual behavior, duration of sex work, number of sex
clients, condom use, number of regular partners and
reproductive history. Menopause data was obtained by self-
report methodology. Participants also underwent HIV
testing and a gynecological exam where vaginal specimens
were obtained and tested for the presence of bacterial
vaginosis (Nugent score), Nisseria gonorrhoeae, and
Chlamydia (PCR). Informed written consent was obtained
from all study participants. Ethics approval for this study
was obtained from both the University of Manitoba and the
University of Nairobi.
Sample collection and processing
CVL
The cervix was washed with 2ml of sterile 1× phosphate-
buffered saline (PBS) and the lavage was collected from
the posterior fornix. Obtained samples were centrifuged
and stored at −70°C. Samples were shipped to Winnipeg,
Manitoba, Canada for analysis.
Plasma
Peripheral blood was collected in EDTA tubes. Plasma
was collected and frozen at −70°C, and shipped to
Winnipeg, Manitoba for further analysis.
Cytokine/Chemokine measurement
Cytokine/chemokine levels were measured using Miliplex
MAP multiplex kit (Human Cytokine/chemokine panel I
and III from Millipore, Billerica, MA) and analyzed on the
BioPlex-200 (Bio-Rad, Mississauga, ON, Canada). Human
cytokine/chemokine panel I was analyzed following the
overnight protocol whereas the human cytokine/chemokine
panel III was analyzed following the 2h incubation protocol.
Human cytokine/chemokine panel I included following
cytokines: IL-1β, IL-2, sIL-2Rα, IL-6, IL-8, IL-10, IL-12p70,IL-15, IL-17, sCD40L, Fractalkine, IFN-γ, IP-10, MCP-1,
MCP-3, MIP-1α, MIP-1β and TNF-α. Human cytokine/
chemokine panel III included following chemokines: ITAC
(CXCL11), MIG (CXCL9), MIP-3α (CCL20) and MIP-3β
(CCL19). Samples with values below the lower detection
limit (MinDC +2SD) were assigned the value half the lower
detection limit in pg/ml, (MinDC + 2SD)/2.
Statistical analysis
Statistical analysis was performed using the GraphPad
Prism (version 5, GraphPad software, La Jolla, CA) and
p values <0.05 were considered to be statistically signifi-
cant. Its important to note that p-values are reported
and discussed as observed and no corrections for
multiple comparison were made [26]. Gaussian distribu-
tion was tested by D’agostino and Pearson’s omnibus
normality test. Since our data did not follow normal dis-
tribution Spearman nonparametric correlation, Kruskal-
Wallis and Mann Whitney non-parametric tests were
used in the analysis. Multivariate analysis was performed
using SPSS for Mac, version 20 (SPSS Inc., Chicago,
Illinois, USA). Outcomes required log transformation to
make the residuals behave properly.
Additional file
Additional file 1: Table S1. Correlation of age and plasma cytokine/
chemokine levels. Table S2. Correlation of age and CVL cytokine/
chemokine levels. Table S3. Linear mixed models analyses to determine
the effect of age and menopause on plasma MIG and MCP-1 expression
in Kenyan FSW cohort.
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